Journey in evolution of nuclear cardiology: Will there be another quantum leap with the f-18-labeled myocardial perfusion tracers?

JACC: Cardiovascular Imaging

Volumn 5, Issue 12, 2012, Pages 1269-1284

  Dilsizian, Vasken ^a   Taillefer, Raymond ^b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cardiac radiotracers; coronary flow reserve; F 18 flurpiridaz; myocardial blood flow; myocardial perfusion imaging; N 13 ammonia; nuclear cardiology; PET; potassium 43; prognosis; rubidium 82; SPECT; Tc 99m sestamibi; Tc 99m tetrofosmin; thallium 201

Indexed keywords

AMMONIA N 13; CADMIUM ZINC TELLURIDE; FLUORODEOXYGLUCOSE F 18; FLURPIRIDAZ F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRIDOCADE TECHNETIUM TC 99M; NITROGEN 13; POTASSIUM 43; RUBIDIUM 82; TEBOROXIME TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; TRACER; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIAGNOSTIC VALUE; HEART FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE PROCESSING; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOLOGY; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEART DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MEDICINE; RADIOACTIVE TRACERS;

EID: 84871370219     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.10.006     Document Type: Review

References (88)

1. W.D. Love, R.B. Romney, G.E. Burch A comparison of the distribution of potassium and exchangeable rubidium in the organs of the dog, using rubidium-86 Circ Res 2 1954 112 122
2. B.L. Zaret, H.W. Strauss, N.D. Martin, H.P. Wells, M.D. Flamm Noninvasive regional myocardial perfusion with radioactive potassium: study of patients at rest with exercise and during angina pectoris N Engl J Med 288 1973 809 812
3. E. Lebowitz, M.W. Greene, R. Fairchild Thallium-201 for medical use I J Nucl Med 16 1975 151 155
4. G.M. Pohost, L.M. Zir, R.H. Moore, K.A. McKusick, T.E. Guiney, G.A. Beller Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201 Circulation 55 1977 294 302
5. E.K. Prokop, H.W. Strauss, J. Shaw, B. Pitt, H.N. Wagner Comparison of regional myocardial perfusion determined by ionic potassium-43 to that determined by microspheres Circulation 50 1974 978 984
6. K.L. Gould, R.A. Goldstein, N. Mullani Noninvasive Assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation VIII. Feasibility of 3D cardiac positron imaging without a cyclotron using generator produced Rb-82 J Am Coll Cardiol 7 1986 775 792
7. L.L. Demer, K.L. Gould, R.A. Goldstein Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patients Circulation 79 1989 825 835
8. N.H.J. Pijls, J.A.M. van Son, R.L. Kirkeeide, B.D. Bruyne, K.L. Gould Experimental basis of determining maximal coronary myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA Circulation 86 1993 1354 1357
9. V. Dilsizian, J. Narula Qualitative and quantitative scrutiny by regulatory process: is the truth subjective or objective? J Am Coll Cardiol Img 2 2009 1037 1038
10. K. Erlandsson, K. Kacperski, D. van Gramberg, B.F. Hutton Performance evaluation of D-SPECT: a novel SPECT system for nuclear cardiology Phys Med Biol 54 2009 2635 2649
11. T. Sharir, S. Ben-Haim, K. Merzon High-speed myocardial perfusion imaging J Am Coll Cardiol Img 1 2008 156 163
12. W.E. Boden, R.A. O'Rourke, K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
13. H.R. Schelbert, M.A. Oxilia-Estigarribia PET quantitation of myocardial blood flow V. Dilsizian, J. Narula, Atlas of Nuclear Cardiology 2003 Current Medicine, Inc. Philadelphia, PA 79 96 Braunwald E (series editor)
14. K.L. Gould, K. Lipscomb, G.W. Hamilton A physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve Am J Cardiol 33 1974 87 94
15. K.L. Gould Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation I. Physiologic basis and experimental validation Am J Cardiol 41 1978 267 278
16. 4+ and emission computed tomography in intact dogs Am J Cardiol 43 1979 200 208
17. H.R. Schelbert, G. Wisenberg, M.E. Phelps Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation Am J Cardiol 49 1982 1197 1207
18. A.P. Selwyn, R.M. Allan, A. L'Abbate Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia Am J Cardiol 50 1982 112 121
19. J.E. Deanfield, A.P. Selwyn, S. Chierchia, A. Maseri, P. Ribeiro, S. Krikler Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes Lancet 2 1983 753 758
20. K.L. Gould Does coronary flow trump coronary anatomy? J Am Coll Cardiol Img 2 2009 1009 1023
21. T.H. Schindler, A. Quercioli, H.R. Schelbert, V. Dilsizian Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health J Am Coll Cardiol Img 3 2010 623 640
22. N.P. Johnson, K.L. Gould Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve J Am Coll Cardiol Img 4 2011 990 998
23. N.P. Johnson, K.L. Gould Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiologic severity J Am Coll Cardiol Img 5 2012 430 440
24. H.R. Schelbert FFR and coronary reserve: friends or foes? J Am Coll Cardiol Img 5 2012 203 206
25. N.P. Johnson, K.L. Gould Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity J Am Coll Cardiol Img 5 2012 430 440
26. K.L. Gould, J.P. Martucci, D.I. Goldberg Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease: a potential noninvasive marker of healing coronary endothelium Circulation 89 1994 1530 1538
27. K.L. Gould, D. Ornish, L. Scherwitz Changes in myocardial perfusion abnormalities by positron emission tomography after long term, intense risk factor modification JAMA 274 1995 894 901
28. S. Sdringolu, K. Nakagawa, Y. Nakagawa Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared to usual care cholesterol lowering drugs in coronary artery disease J Am Coll Cardiol 41 2003 262 272
29. T.H. Schindler, E.U. Nitzsche, T. Munzel Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration J Am Coll Cardiol 42 2003 814 822
30. J. Czernin, R.J. Barnard, K.T. Sun Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve Circulation 92 1995 197 204
31. D. Baller, G. Notohamiprodjo, U. Gleichmann, J. Holzing, R. Weise, J. Lehmann Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis Circulation 99 1999 2871 2875
32. S.K. Bennett, M.F. Smith, S.S. Gottlieb, M.L. Fisher, S.L. Bacharach, V. Dilsizian Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or non-ischemic cardiomyopathy Am J Cardiol 89 2002 1431 1434
33. B.A. Herzog, L. Husmann, I. Valenta Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography J Am Coll Cardiol 54 2009 150 156
34. M.C. Ziadi, R.A. deKemp, K.A. Williams Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia J Am Coll Cardiol 58 2011 740 748
35. V.L. Murthy, M. Naya, C.R. Foster Improved cardiac risk assessment with noninvasive measures of coronary flow reserve Circulation 124 2011 2215 2224
36. K. Fukushima, M.S. Javadi, T. Higuchi Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging J Nucl Med 52 2011 726 732
37. M. Fiechter, J.R. Ghadri, C. Gebhard Diagnostic value of 13N-ammonia myocardial perfusion PET: added value of myocardial flow reserve J Nucl Med 53 2012 1230 1234
38. V.L. Murthy, M. Naya, C.R. Foster Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus Circulation 126 2012 1858 1868
39. F. Cecchi, I. Olivotto, R. Gistri Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027 1035
40. D. Neglia, C. Michelassi, M.G. Trivieri Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction Circulation 105 2002 186 193
41. M.A. Lodge, H. Braess, F. Mahmoud Developments in nuclear cardiology: transition from single photon emission computed tomography to positron emission tomography-computed tomography J Invasive Cardiol 17 2005 491 496
42. H.W. Strauss, B. Pitt Thallium 201 as a myocardial perfusion imaging agent Semin Nucl Med 7 1977 49 58
43. K.F. Van Train, J. Maddahi, D.S. Berman Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial J Nucl Med 31 1990 1168 1179
44. V. Dilsizian Connectivity of radiotracers to vasodilators: is thallium the missing link? J Am Coll Cardiol Img 2 2009 1209 1212
45. V. Dilsizian, T.P. Rocco, N.M. Freedman, M.B. Leon, R.O. Bonow Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging N Engl J Med 323 1990 141 146
46. A.J. Einstein Breaking America's dependence on imported molybdenum J Am Coll Cardiol Img 2 2009 369 371
47. V. Dilsizian, J. Narula Seeking remedy for Molly's woe: time for a thallium pill? J Am Coll Cardiol Img 2 2009 375 377
48. E. Deutsch, W. Bushong, K.A. Glavan Heart imaging with cationic complexes of technetium Science 214 1981 85 86
49. R. Dudczak, P. Angelberger, R. Homan Evaluation of 99mTc-dichloro bis (1,2-dimethylphosphino) ethane (99mTc-DMPE) for myocardial scintigraphy in man Eur J Nucl Med 8 1983 513 515
50. A.G. Jones, A. Davison, S. Abram Biological studies of a new class of technetium complexes: the hexakis (alkylisonitrile) technetium (I) cations Int J Nucl Med Biol 11 1984 225 234
51. B.L. Holman, A.G. Jones, J. Lister-James A new Tc-99m-labelled imaging agent, hexakis (T-butyl-isonitrile)-technetium (I) (Tc-99m TBI): initial experience in the human J Nucl Med 25 1984 1350 1355
52. R.D. Okada, D. Glover, T. Gaffney Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonirile Circulation 77 1988 491 498
53. R. Taillefer, G. Dupras, V. Sporn Myocardial perfusion imaging with a new radiotracer, technetium-99m-hexamibi (methoxy isobutyl isonitrile): comparison with thallium-201 imaging Clin Nucl Med 14 1989 89 96
54. V. Dilsizian, T.P. Rocco, H.W. Strauss Technetium-99m isonitrile myocardial uptake at rest I. Relation to severity of coronary artery stenosis J Am Coll Cardiol 14 1989 1673 1677
55. R.K. Narra, A.D. Nunn, B.L. Kuczynski A neutral technetium-99m complex for myocardial imaging J Nucl Med 30 1989 130 136
56. R.J. Di Rocco, W.L. Rumsey, B.L. Kuczynski Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201 J Nucl Med 33 1992 1152 1159
57. D. Jain, F.J.T. Wackers, J. Mattera Biokinetics of technetium-99m- tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol J Nucl Med 34 1993 1254 1259
58. B. Higley, F.W. Smith, T. Smith Technetium-99m-1,2-bis(bis(2-ethoxyethyl) phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent J Nucl Med 34 1993 30 38
59. R. Taillefer, E.G. DePuey, J.E. Udelson Comparative diagnostic accuracy of thallium-201 and 99mTc-sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women J Am Coll Cardiol 29 1997 69 77
60. D. Fagret, P.Y. Marie, F. Brunotte Myocardial perfusion imaging with technetium-99m-TC NOET: comparison with thallium-201 and coronary angiography J Nucl Med 36 1995 936 943
61. M.S. Verani, M.O. Jeroudi, J.J. Mahmarian Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile J Am Coll Cardiol 12 1988 1573 1581
62. L. Bilodeau, P. Théroux, J. Grégoire Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical electrocardiographic and angiographic findings J Am Coll Cardiol 18 1991 1684 1691
63. T.F. Christian, I.P. Clements, R.J. Gibbons Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m sestamibi Circulation 83 1991 1615 1620
64. T.F. Christian, R.S. Schwartz, R.J. Gibbons Determination of infarct size in reperfusion therapy for acute myocardial infarction Circulation 86 1992 81 90
65. E.G. DePuey, A. Rozanski Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artefact J Nucl Med 36 1995 952 955
66. D.S. Berman, R. Hachamovitch, H. Kiat Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography J Am Coll Cardiol 26 1995 639 647
67. R. Hachamovitch, D.S. Berman, H. Kiat Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification Circulation 93 1996 905 914
68. J.E. Udelson, P.S. Coleman, J. Metherall Predicting recovery of severe regional ventricular dysfunction Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi Circulation 89 1994 2552 2561
69. V. Dilsizian, J.A. Arrighi, J.G. Diodati Myocardial viability in patients with chronic coronary artery disease: comparison of 99mTc-sestamibi with thallium reinjection and (18F) fluorodeoxyglucose Circulation 89 1994 578 587
70. V. Dilsizian, S.L. Bacharach, R.S. Beanlands ASNC imaging guidelines for nuclear cardiology procedures: PET myocardial perfusion and metabolism. clinical imaging J Nucl Cardiol 16 2009 651
71. S.R. Bergmann, K.A. Fox, A.L. Rand Quantification of regional myocardial blood flow in vivo with H215O Circulation 70 1984 724 733
72. S.R. Bergmann, P. Herrero, J. Markham, C.J. Weinheimer, M.N. Walsh Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography J Am Coll Cardiol 14 1989 639 652
73. R. Lautamaki, R.T. George, K. Kitagawa Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis Eur J Nucl Med Mol Imaging 36 2009 576 586
74. R.T. Go, T.H. Marwick, W.J. MacIntyre A prospective comparison of rubidium-82 PET and thallium-201 SPECT in myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease J Nucl Med 31 1990 1899 1905
75. K. Yoshida, N. Mullani, K.L. Gould Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia J Nucl Med 37 1996 1701 1712
76. H.R. Schelbert, M.E. Phelps, S.C. Huang N-13 ammonia as an indicator of myocardial blood flow Circulation 63 1981 1259 1272
77. J. Krivokapich, G.T. Smith, S.C. Huang 13N ammonia myocardial imaging at rest and with exercise in normal volunteers Quantification of absolute myocardial perfusion with dynamic positron emission tomography Circulation 80 1989 1328 1337
78. G.D. Hutchins, M. Schwaiger, K.C. Rosenspire Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging J Am Coll Cardiol 15 1990 1032 1042
79. 13N-Ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization J Am Coll Cardiol 33 1999 678 686
80. M.M. Hajjiri, M.B. Leavitt, H. Zheng Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location J Am Coll Cardiol Img 2 2009 751 758
81. R.M. Hollingworth, K.I. Ahammadsahib, G. Gadelhak, J.L. McLaughlin New inhibitors of complex I of the mitochondrial electron transport chain with activity as pesticides Biochem Soc Trans 22 1994 230 233
82. G.S. Gurm, S.B. Danik, T.M. Shoup 4-[18F]-Tetraphenyl-phosphonium as a PET tracer for myocardial mitochondrial membrane potential J Am Coll Cardiol Img 5 2012 285 292
83. P. Yalamanchili, E. Wexler, M. Hayes Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent J Nucl Cardiol 14 2007 782 788
84. M. Yu, M.T. Guaraldi, M. Mistry BMS-747148-02: a novel PET myocardial perfusion imaging agent J Nucl Cardiol 14 2007 789 798
85. S.G. Nekolla, S. Reder, A. Saraste Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model Circulation 119 2009 2333 2342
86. J. Maddahi, J. Czernin, J. Lazewatsky Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest J Nucl Med 52 2011 1490 1498
87. J. Maddahi Properties of an ideal PET perfusion tracer: New PET tracer cases and data J Nucl Cardiol 19 Suppl 1 2012 S30 S37
88. W.K. Laskey, L.E. Feinendegen, R.D. Neumann, V. Dilsizian Low-level ionizing radiation from non-invasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? J Am Coll Cardiol Img 3 2010 517 524